Verona Pharma Plc (VRP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The companys lead candidate, RPL554 is a bronchodilator/anti-inflammatory drug which is being developed for a wide range of indications including chronic obstructive pulmonary disease (COPD), cystic fibrosis and asthma. The company has collaborations with Kings College London McGill University and The University of North Carolina for conducting research and experimental studies and to the fund exploratory studies. It has operations across North America and the UK. Verona Pharma is headquartered in London, the UK.

Verona Pharma Plc (VRP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Verona Pharma Enters into Agreement with European Technology Companies 11
Equity Offering 12
Verona Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 12
Verona Pharma Raises USD78 Million in Public Offering of Shares 13
Verona Pharma Announces Exercise of Over-Allotment Option for Public Offering of ADS for USD87.2 Million 14
Verona Pharma Raises USD2 Million in Private Placement of Shares 16
Verona Pharma Raises USD63 Million in Private Placement of Units 17
Verona Pharma Raises USD21.7 Million in Private Placement of Shares 20
Verona Pharma Completes Rights Offering Of Shares For US$1.7 Million 21
Verona Pharma Announces Private Placement Of Shares For US$1.3 Million 22
Verona Pharma Prices Private Placement Of Shares For US$2 Million 23
Verona Pharma Announces Private Placement Of Shares For US$8 Million 24
Verona Pharma Plc - Key Competitors 25
Verona Pharma Plc - Key Employees 26
Verona Pharma Plc - Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
May 08, 2018: Verona Pharma Operational Update and Financial Results for the First Quarter Ended March 31, 2018 28
Feb 27, 2018: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017 32
Nov 07, 2017: Verona Pharma Operational Update and Financial Results for the Third Quarter Ended September 30, 2017 39
Aug 08, 2017: Verona Pharma Interim Results for the Six Months Ended June 30, 2017 41
Feb 27, 2017: Verona Pharma Announces Financial results for the year ended 31 December 2016 42
Corporate Communications 44
Apr 11, 2018: Verona Pharma Announces Departure of Chief Medical Officer 44
Apr 03, 2017: Verona Pharma announces new collaborations to develop dry powder and MDI formulations for COPD 45
Apr 03, 2017: Verona Pharma Announces Board Change 46
Mar 31, 2017: Verona Pharma appoints commercial director 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List Of Tables

List of Tables
Verona Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Verona Pharma Enters into Agreement with European Technology Companies 11
Verona Pharma Plans to Raise up to USD200 Million in Public Offering of Securities 12
Verona Pharma Raises USD78 Million in Public Offering of Shares 13
Verona Pharma Announces Exercise of Over-Allotment Option for Public Offering of ADS for USD87.2 Million 14
Verona Pharma Raises USD2 Million in Private Placement of Shares 16
Verona Pharma Raises USD63 Million in Private Placement of Units 17
Verona Pharma Raises USD21.7 Million in Private Placement of Shares 20
Verona Pharma Completes Rights Offering Of Shares For US$1.7 Million 21
Verona Pharma Announces Private Placement Of Shares For US$1.3 Million 22
Verona Pharma Prices Private Placement Of Shares For US$2 Million 23
Verona Pharma Announces Private Placement Of Shares For US$8 Million 24
Verona Pharma Plc, Key Competitors 25
Verona Pharma Plc, Key Employees 26
Verona Pharma Plc, Subsidiaries 27

List Of Figures

List of Figures
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verona Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Verona Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 9

Verona Pharma Plc (VRP) - Medical Equipment - Deals and Alliances Profile

Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory

USD 250 View Report

Verona Pharma Plc (VRP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory

USD 250 View Report

Destiny Pharma Plc (DEST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development

USD 250 View Report

Midatech Pharma Plc (MTPH) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Midatech Pharma Plc (Midatech) is a pharmaceutical company that develops and commercializes products in oncology and other therapeutic areas. The companys products include gelclair, oravig, soltamox and zuplenz. It conducts

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available